NovaBay Pharmaceuticals, Inc. NBY 深 滬
已收盤 07-25 16:00:00 美东时间
0.6724
+0.021
+3.24%
華盛通- 最 高0.689
- 今 開0.6648
- 成交量 11.81万股
- 最 低 0.6515
- 昨 收 0.6513
- 總市值 391.08万
- 52周最高 1.0099
- 市盈率 靜 --
- 換手率 2.03%
- 52周最低 0.3611
- 委 比 85.30%
- 總股本 581.62万
- 歷史最高 62168.75
- 量 比 6.28
- 振 幅 5.76%
- 歷史最低 0.46
- 每 手 1
- 風險率 0.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)
Ascendiant Capital analyst Edward Woo maintains NovaBay Pharmaceuticals (AMEX:NBY) with a Buy, adjusts target to $0.85 from $8 (1-35 Reverse Stock Split).
2024-11-12 01:44
NovaBay accepts higher PRN offer, says Refresh deal no longer superior
NovaBay (NYSE:NBY) said it has accepted a revised offer from PRN Physician Recommended Nutriceuticals that increases the base purchase price of its Avenova eyecare business to $11.5M from $9.5M. In ad...
2024-11-07 05:49
NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions
NovaBay Pharmaceuticals (NYSE:NBY) announced on Tuesday that it has received an unsolicited, non-binding offer from Refresh Acquisitions to purchase its Avenova brand, which it deems a "superior propo...
2024-10-29 21:00
NovaBay Pharma Plans Special Meeting for Asset Sale
An update from NovaBay Pharma ( ($NBY) ) is now available. NovaBay Pharmaceutic...
2024-10-17 04:48
What's Going On With NovaBay Pharmaceuticals Shares Friday?
NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.
2024-09-21 01:28
NovaBay Pharma Announces Avenova Sale and Planned Dissolution
The latest update is out from NovaBay Pharma ( ($NBY) ). NovaBay Pharmaceutical...
2024-09-20 20:28
NovaBay Pharmaceuticals to sell Avenova assets for $9.5M
NovaBay Pharmaceuticals (NYSE:NBY) said it will sell the assets of the Avenova brand for $9.5M in cash. The firm has signed an agreement with PRN Physician Recommended Nutriceuticals for the deal. The...
2024-09-20 20:07
Eyenovia appoints Andrew Jones as CFO
Eyenovia (NASDAQ:EYEN) said it has appointed Andrew Jones as its finance chief. Jones has over three decades of experience, and most recently served as the finance chief of NovaBay Pharmaceuticals. EY...
2024-09-03 19:39
NovaBay Pharmaceuticals Q2 EPS $(1.37) Misses $(1.23) Estimate, Sales $2.40M Miss $3.15M Estimate
NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(1.23) by 11.38 percent. This is a 96.92 percent increase over losses of $(44.43) per
2024-08-14 04:06
快讯 | novabay pharmaceuticals公司报告2024年第二季度财务业绩
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
2024-08-14 04:05
